Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer ...

The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in ...

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.

A Look at Heated Compression Foot Massagers and Where the EMSense Triple Therapy Device Sits in the Wider Conversation About At-Home Foot Comfort and Circulation Support An overview of the growing ...

Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential ...

UCSF has launched the Alzheimer's Tau Platform (ATP) trial, the first large-scale clinical trial testing combination therapies that target both amyloid plaques and tau tangles simultaneously.

The road to menopause is paved with symptoms such as hot flashes, night sweats, and vaginal dryness. But, while normal, they shouldn’t have an outsize impact on your life. That’s where hormone therapy ...

Adding venetoclax to hypomethylating agents increased composite remission but did not improve overall survival in HR-MDS.

InxMed Co., Ltd ('InxMed'), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical ...

Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive form of brain cancer: resistance to chemotherapy. The ...

Dr. Monty Pal compares the available immunotherapy plus tyrosine kinase inhibitor (IO/TKI) combination regimens for the first-line treatment of advanced renal cell carcinoma (RCC) and explains the ...

For youths with anxiety disorders, similar symptom reduction is seen with fluoxetine, cognitive behavioral therapy (CBT) and their combination, according to a study published online June 24 in The ...